Société des Industries Pharmaceutiques de Tunisie - S.A. (BVMT:SIPHA)
Tunisia · Delayed Price · Currency is TND 4.200
0.00 (0.00%)
At close: Aug 6, 2025
Société des Industries Pharmaceutiques de Tunisie - Company Description
Société des Industries Pharmaceutiques de Tunisie - S.A. engages in the research, development, manufacture, packaging, and marketing of pharmaceutical products for human use in Tunisia and internationally.
It provides rheumatology drugs, such as MYORELAX, NIFLUMIC, and ALGESAL SURACTIVE; stomatology drugs, including HEXABAIN; and ANALGAN CODEINE 300mg/25mg indicated for the symptomatic treatment of moderate and intense pain.
The company was founded in 1989 and is headquartered in Ben Arous, Tunisia.
Société des Industries Pharmaceutiques de Tunisie - S.A.
| Country | Tunisia |
| Founded | 1989 |
| Industry | Pharmaceutical Preparations |
| Employees | 744 |
| CEO | Anis Klouz |
Contact Details
Address: Fondouk Choucha Ben Arous, 2013 Tunisia | |
| Phone | 216 71 381 222 |
| Website | siphat.rns.tn |
Stock Details
| Ticker Symbol | SIPHA |
| Exchange | Tunis Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TND |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Anis Klouz | Chief Executive Officer |